Effect of dietary supplementation with long-chain n-3 fatty acids during late gestation and early lactation on mare and foal plasma fatty acid composition, milk fatty acid composition, and mare reproductive variables.

The effects of dietary marine-derived n-3 fatty acids (FA) on mare milk and mare and foal plasma FA, postpartum ovarian follicular growth and prostaglandin concentrations were evaluated. Sixty days prior to expected foaling dates, mares were assigned to one of three diets: corn oil (CORN, n = 6), docosahexaenoic acid (DHA) diet (D; 12.64 g/d, n = 7), or eicosapentaenoic acid (EPA) and DHA (ED; 8.84 g EPA, 10.43 g DHA/d, n = 7). Milk and plasma were collected for FA analysis. Follicular data were recorded through the first postpartum ovulation. Post-ovulation serial blood samples were evaluated for prostaglandin F2α metabolite (PGFM). Supplementation with DHA, or DHA plus EPA resulted in lower linoleic acid and greater EPA and DHA in mare plasma (P < 0.05), greater arachidonic acid and DHA, or EPA and DHA in milk (P < 0.05), and greater DHA, or EPA and DHA in foal plasma (P < 0.05). Days to the first postpartum ovulation was greater (P < 0.01) in ED (22.5 ± 2.1) compared to CORN (12.5 ± 2.3) and D (13.3 ± 2.3) groups. Follicular retention (≥35 mm) prior to ovulation was longer (P < 0.05) for ED (12.7 ± 1.9 d) compared to CORN (6.3 ± 2.0 d) or D (6.0 ± 2.0 d) groups. Treatment did not affect PGFM concentrations. Maternal EPA and DHA supplementation beginning in late gestation altered the FA profile of milk and mare and foal plasma, and may result in delayed ovulation in the early postpartum period.

Ovulation and fertility responses for sows receiving once daily boar exposure after weaning and OvuGel® followed by a single fixed time post cervical artificial insemination.

Boar exposure is used to stimulate follicle development and estrus in sows after weaning and also to improve semen uptake and sperm transport with insemination. However, the need and value of boar exposure is uncertain when ovulation induction is used. These studies were designed to determine the effect of daily boar exposure after weaning when used with ovulation induction and fixed time post-cervical artificial insemination (PCAI). In experiment 1, sows were weaned into stalls and assigned to receive 3 min of daily fenceline boar exposure (BE, n = 7) or no boar exposure (NBE, n = 8). All sows received OvuGel at 96 h after weaning and BE or NBE 30 min prior to a single PCAI 24 h after OvuGel. Ovaries were assessed daily for follicle size from weaning until ovulation. Cervical contractions were measured 30 min following BE or NBE and before PCAI, while uterine contractions were measured for 1 h following PCAI. In experiment 2, weaned sows (n = 244) were assigned by parity to receive once daily BE for 1.5 min each day or NBE. OvuGel, PCAI and ultrasound methods were performed similarly as in experiment 1. Results from experiment 1 indicated BE did not significantly influence follicle size or measures of fertility. However, BE did increase the frequency of cervical contractions (P < 0.05), but with no effect on the uterus. Results from experiment 2 indicated BE had no effect on catheter passage for PCAI but did increase the proportion of sows ovulating within 48 h after OvuGel (77.7 vs 67.5%, P = 0.05), and tended (P = 0.10) to increase the proportion of sows inseminated 24 h before ovulation (70.3 vs. 61.0%). However, BE had no effect on adjusted farrowing rate (84.4 vs. 77.4%) or total pigs born (13.2 vs. 12.5) for BE and NBE, respectively. There were treatment and parity interactions for follicle size at time of OvuGel and at time of PCAI (P < 0.05) with BE minimizing parity effects on follicle size. Parity effects were also evident on farrowing rate and litter size when inseminations occurred >24 h from ovulation but not when inseminations occurred ≤24 h before ovulation. The results indicate that boar exposure for only minutes each day after weaning had beneficial effects for improving follicle development, ovulation induction, and AI timing, most notably in parity 1 sows, but had no beneficial or detrimental effects on the ability to perform PCAI.

Design and biological effects of a vaginally administered gel containing the GnRH agonist, triptorelin, for synchronizing ovulation in swine.

A novel gel formulation was selected for intravaginal delivery of the GnRH agonist (triptorelin) for synchronizing ovulation in pigs. Studies with gilt models were used to assess LH response profiles. The lowest dose of triptorelin that induced the most gilts to show an LH surge was 100 µg in 1.2% methylcellulose gel. This formulation had a similar effect in weaned sows while also advancing ovulation. The timing of administration was evaluated in sows after weaning. Administration at 96 h induced more sows to ovulate (58%) by 48 h compared to treatment at estrus (45%) or for controls (34%), but the desired level of ovulation synchrony was not achieved. As a result, greater doses of triptorelin were tested and 200 µg given at 96 h after weaning, induced 81% of sows to ovulate within 48 h after treatment. The best synchrony of ovulation occurred when given at 96 h after weaning compared to earlier or later intervals. The optimum time to give a single fixed time AI (SFT-AI) after administration of 200 µg of triptorelin in 1.2% gel (OvuGel®) at 96 h after weaning was tested. A SFT-AI at 22 ± 2 h after OvuGel achieved the highest fertility and was practical for staff during the normal work day. In field trials, a SFT-AI 22 ± 2 h after all weaned sows were treated with OvuGel improved (P = 0.04) farrowing rate to 82.5% compared to control sows weaned (80.1%), with no effect on numbers of pigs born alive (12.1). Research continues for identifying the advantages for use of OvuGel in different production systems, and potential application for use in gilts.

Effects of estrus synchronization using Matrix® followed by treatment with the GnRH agonist triptorelin to control ovulation in mature gilts.

Estrus and ovulation responses in Matrix-treated gilts may affect ovulation synchrony in response to triptorelin. In experiment 1, estrus and ovulation measures at 12h intervals after last Matrix feeding (LMF) were analyzed. For the 398 gilts that displayed estrus, 87.4% were detected on Days 6-8 after LMF. Duration of estrus was 24-60h for 85.6% of gilts and negatively correlated with interval from LMF to estrus (r=-0.53, P<0.0001). The estrus to ovulation interval was positively correlated with duration of estrus (r=0.61, P<0.0001). In experiment 2, gilts (n=96) received intravaginal treatment with 2mL of gel containing placebo (Control) at 96h, 200µg of triptorelin at 96h (TRP96), 120h (TRP120) or 144h (TRP144) after LMF. Estrus measures did not differ (P>0.10) among treatments. The proportion of gilts ovulating 32-56h after treatment was greater for TRP120 and TRP144 (P<0.01) compared to other treatments. The treatment to ovulation intervals for all triptorelin treatments were shorter (P<0.001) than Control. In experiment 3, gilts (n=86) received placebo (Control), 100µg (TRP100), 200µg (TRP200), or 400µg (TRP400) of triptorelin at 120h after LMF. There was no effect of treatment (P>0.10) on estrus or on interval from LMF to estrus. The proportion of gilts ovulating by 40, 48 and 56h after treatment increased (P<0.05) with triptorelin compared to Control. Our results indicate that gilts receiving 100-400µg of triptorelin at 120h after LMF had the greatest ovulation synchrony 24-48h following treatment. These studies provide important information for developing a procedure for a single insemination in synchronized gilts.

Evaluation of an intravaginal triptorelin acetate gel for inducing ovulation in mares.

The objective of these studies was to investigate the efficacy of an intravaginal triptorelin acetate (TA) gel as an ovulation-inducing agent in mares. In Exp. 1, 24 mares were blocked using a combination of parity and age and randomly assigned to 1 of 3 treatment groups: 5 mL TA gel (TA5), 10 mL TA gel (TA10), or 5 mL vehicle gel only (CON). Following the appearance of a follicle ≥ 25 mm, a blood sample was obtained for measurement of LH from each mare every 24 h until treatment administration. When a follicle ≥ 35 mm was observed, treatments were administered intravaginally. Following treatment, blood samples were collected for measurement of LH and ovaries were scanned via ultrasonography every 12 h until 48 h post-ovulation. Mares in both TA5 and TA10 tended ( = 0.08) to experience a brief surge in LH by 12 h post-treatment. There was a treatment by time interaction ( < 0.005). The interval from treatment to ovulation was not different between groups ( > 0.05). We hypothesized that duration of elevated LH was not sufficient to induce ovulation in most mares. In Exp. 2, 23 mares were blocked by parity/age and randomly assigned to 3 treatment groups: the CON ( = 7) and TA5 ( = 8) treatment groups remained the same, but the TA10 treatment was split into two 5-mL doses administered 24 h apart (TA5×2; = 8). Blood collection and ultrasonography occurred every 12 h on detection of a follicle ≥ 25 mm in diameter. Once a follicle ≥ 35 mm was detected, treatment was administered and ultrasonography and blood collection for measurement of LH occurred every 6 h until 48 h post-ovulation to get a more robust characterization of the effect of TA on LH and a more accurate timeframe in which ovulation was occurring. Mares in both TA5 and TA5×2 had an increase ( < 0.05) in LH by 6 h post-treatment, which was declining by 12 h post-treatment. Following the second dose in TA5×2, another rise in LH occurred, but to a lesser magnitude ( > 0.05) compared with the initial dose. Again there was a treatment by time interaction ( < 0.005) and in Exp. 2 the interval from treatment to ovulation was shorter in TA5 (61.5 ± 8.8 h) and TA5×2 (61.5 ± 9.6 h) compared with CON (123.1 ± 21.7 h; < 0.01). In Exp. 2, administration of TA gel increased LH concentrations and hastened the interval from treatment to ovulation in mares, without an advantage in the timing of ovulation noted between the 5 or 10-mL doses, or administration of two 5-mL doses given 24 h apart.

Effect of numbers of sperm and timing of a single, post-cervical insemination on the fertility of weaned sows treated with OvuGel®.

Variability in estrus and ovulation requires multiple inseminations during estrus to ensure one AI occurs close to ovulation. Induction of ovulation after weaning improves synchrony of ovulation and allows for fixed time AI. However, the interaction between number of sperm in the AI dose and the timing of insemination has not been fully investigated. The objective of this study was to determine the effects of sperm numbers used in a single post-cervical insemination (PCAI) and the timing of insemination following induced ovulation in weaned sows. The experiment was performed using sows (n = 641) allotted by parity (1-6) and lactation length (19.5 d) to receive a single PCAI using 1.5 or 2.5 billion motile sperm at either 22, 26, or 30 h following administration of a GnRH agonist, triptorelin acetate (OvuGel®) at 96 h post-weaning. Sows received boar contact once daily 3-6 d following weaning. A sub-population of the sows (n = 499) were assessed for follicle size and ovulation utilizing ultrasound at 8 h intervals. There was no interaction of number of sperm and timing of insemination for any response measure (P > 0.10). Wean to estrus interval (4.8 d), duration of estrus (1.9 d), and expression of estrus (88.0%), were not different among treatments (P > 0.10). Of sows scanned by ultrasound at the time of OvuGel®, 88.2% had large follicles, 10.9% had small, medium or cystic sized follicles, and 0.9% had corpora lutea. The proportion of sows that ovulated averaged 94%, and differed by time of AI (P ≤ 0.05) but not by number of sperm. Pregnancy rate and farrowing rate tended to be affected by dose (P ≤ 0.10), while time of insemination affected pregnancy rate and tended to influence farrowing rate (P ≤ 0.10). Farrowing rate was greater (P < 0.0001) with use of 2.5 than 1.5 billion sperm and insemination at 22 and 26 h compared to 30 h after OvuGel® (P ≤ 0.10). Farrowing rate was also affected by parity, estrus expression, ovulation and ovarian abnormalities (P < 0.05). Of the 12% of weaned sows that did not exhibit estrus, approximately 50% farrowed a litter. Total born and born alive were affected by dose (P < 0.05) but not time of insemination with both measures increased with 2.5 compared to 1.5 billion sperm (P < 0.05). The results of this study indicate that induction of ovulation in weaned sows resulted in 88% of sows ovulating within a 24 h period. Fertility was improved with a single, fixed time AI using 2.5 compared to 1.5 billion motile sperm and insemination at 22-26 h after OvuGel® compared to 30 h.

Effects of altering the dose and timing of triptorelin when given as an intravaginal gel for advancing and synchronizing ovulation in weaned sows.

Previous studies have shown that triptorelin gel (TG) given intravaginally in gel form is effective for advancing the time of ovulation in weaned sows. Three experiments were performed to determine the effects of altering the dose and timing of administration of intravaginal TG for advancing and synchronizing ovulation in weaned sows. In all experiments, estrus was detected twice or three times daily and ultrasound was performed to determine ovulation at 8-hour intervals. In experiment 1, sows (n = 131) received intravaginal gel containing 0 (Placebo), 25, 100, or 200 µg of TG at 96 hours after weaning and sows were inseminated on each day of standing estrus. Wean-to-estrus interval and duration of estrus were correlated (P < 0.0001) with estrus duration longer in TG (P < 0.05) compared with Placebo. More sows ovulated (P < 0.001) by 48 hours after treatment with 200 (81%), 100 (64%), and 25 µg (63%) of TG compared with Placebo (42%). The farrowing rate and total pigs born did not differ (P > 0.10). In experiment 2, sows (n = 126) received 200 µg of TG at 72, 84, or 96 hours after weaning or were untreated (Control-96). Sows receiving TG were inseminated once 24 to 28 hours after treatment. Control-96 sows were inseminated on each day of standing estrus. Wean-to-estrus interval was not affected by treatment, but wean-to-ovulation interval was reduced (P < 0.05) by TG-72 and TG-84 compared with TG-96 and Control-96. More sows ovulated 40 hours after treatment (P < 0.001) with TG-72 (56.5%) and TG-84 (32.2%) compared with TG-96 and Control-96 (13%) and for all TG treatments 48 hours after treatment (64%) compared with Control-96 (34%, P < 0.05). The farrowing rate was lower (P < 0.05) for sows assigned to TG-72 and TG-84 compared with TG-96 and Control-96, whereas the number of liveborn pigs did not differ (P > 0.10). In experiment 3, sows (n = 113) were assigned to receive no treatment (Control), intravaginal gel alone (Placebo), or 200 µg of TG given intravaginally (OvuGel) at 96 hours after weaning. Wean-to-estrus interval did not differ, but the duration of estrus tended (P < 0.10) to be reduced with OvuGel compared with the other treatments. More sows ovulated (P < 0.001) by 48 hours after OvuGel treatment (79.1%) compared with Control (46.4%) and Placebo (37.9%) and by 56 hours (P < 0.05). The farrowing rate and the number of liveborn pigs did not differ among treatments. The results of these studies indicate that 200 µg of TG given intravaginally at 96 hours after weaning (OvuGel) synchronizes ovulation and results in fertility similar to Controls.

Effect of essential fatty acid and zinc supplementation during pregnancy on birth intervals, neonatal piglet brain myelination, stillbirth, and preweaning mortality.

Omega fatty acids and zinc contribute to physiological pathways that could affect the farrowing process, stillbirth, preweaning mortality, and postweaning return to estrus. To determine effects of omega fatty acids and zinc on these reproductive traits, gilts were mated and fed either a control diet, a diet supplemented with 1.09% Gromega, a diet supplemented with 0.07% zinc sulfate, or a diet supplemented with both Gromega and zinc sulfate from d 80 of gestation until farrowing. Farrowings were video recorded to obtain birth intervals for each piglet, and the number of live and stillborn piglets was recorded. On d 1 after farrowing, piglets were weighed, and the smallest piglet in each litter was sacrificed. A blood sample was collected to measure the immunoglobulin immunocrit ratio, and brain, cerebellum, brain stem, full and empty stomach (to calculate stomach content weight), and heart weights were recorded. Because myelination of specific brain regions may affect preweaning mortality, brain stem, cerebellum, and spinal cord tissues were measured for content of myelin basic proteins and myelin lipids. For remaining piglets, survival to weaning and weaning weights were recorded. Results indicated a weak positive correlation (r = 0.23, P < 0.05) between immunocrit values and brain stem high molecular weight myelin basic protein. There was also a Gromega × zinc supplementation interaction (P < 0.05) on brain stem high molecular weight myelin basic protein in which the combined treatment was greater than the control or each supplement alone. Zinc treatment decreased stillbirth rate during prolonged farrowing and subsequent preweaning survival of low birth weight piglets. Gromega increased overall stillbirth rate and increased the stillbirth rate during prolonged farrowing. There were no relationships between myelin measurements and preweaning survival. In conclusion, combined Gromega and zinc supplementation appeared to improve myelination, but zinc alone improved stillbirth and preweaning survival.

Responses to n-3 fatty acid (LCPUFA) supplementation of gestating gilts, and lactating and weaned sows.

Feeding n-3 long-chain polyunsaturated fatty acids (LCPUFA) to gilts or sows has shown different responses to litter growth, pre-weaning mortality and subsequent reproductive performance of the sow. Two hypotheses were tested: (1) that feeding a marine oil-based supplement rich in protected n-3 LCPUFAs to gilts in established gestation would improve the growth performance of their litters; and (2) that continued feeding of the supplement during lactation and after weaning would offset the negative effects of lactational catabolism induced, using an established experimental model involving feed restriction of lactating primiparous sows. A total of 117 primiparous sows were pair-matched at day 60 of gestation by weight, and when possible, litter of origin, and were allocated to be either control sows (CON) fed standard gestation and lactation diets, or treated sows (LCPUFA) fed the standard diets supplemented with 84 g/day of a n-3 LCPUFA rich supplement, from day 60 of first gestation, through a 21-day lactation, and until euthanasia at day 30 of their second gestation. All sows were feed restricted during the last 7 days of lactation to induce catabolism, providing a background challenge against which to determine beneficial effects of n-3 LCPUFA supplementation on subsequent reproduction. In the absence of an effect on litter size or birth weight, n-3 LCPUFA tended to improve piglet BW gain from birth until 34 days after weaning (P = 0.06), while increasing pre-weaning mortality (P = 0.05). It did not affect energy utilization by the sow during lactation, thus not improving the catabolic state of the sows. Supplementation from weaning until day 30 of second gestation did not have an effect on embryonic weight, ovulation rate or early embryonic survival, but did increase corpora lutea (CL) weight (P = 0.001). Eicosapentaenoic acid and docosahexaenoic acid (DHA) levels were increased in sow serum and CL (P < 0.001), whereas only DHA levels increased in embryos (P < 0.01). In conclusion, feeding n-3 LCPUFA to gilts tended to improve litter growth, but did not have an effect on overall subsequent reproductive performance.

Omega-3 fatty acids in the gravid pig uterus as affected by maternal supplementation with omega-3 fatty acids.

Two experiments evaluated the ability of maternal fatty acid supplementation to alter conceptus and endometrial fatty acid composition. In Exp. 1, treatments were 1) the control, a corn-soybean meal diet; 2) flax, the control diet plus ground flax (3.75% of diet); and 3) protected fatty acids (PFA), the control plus a protected fish oil source rich in n-3 PUFA (Gromega, JBS United Inc., Sheridan, IN; 1.5% of diet). Supplements replaced equal parts of corn and soybean meal. When gilts reached 170 d of age, PG600 (PMSG and hCG, Intervet USA, Millsboro, DE) was injected to induce puberty, and dietary treatments (n = 8/treatment) were initiated. When detected in estrus, gilts were artificially inseminated. On d 40 to 43 of gestation, 7 gilts in the control treatment, 8 gilts in the PFA treatment, and 5 gilts in the flax treatment were pregnant and were slaughtered. Compared with the control treatment, the flax treatment tended to increase eicosapentaenoic acid (EPA: C20:5n-3) in fetuses (0.14 vs. 0.25 +/- 0.03 mg/g of dry tissue; P = 0.055), whereas gilts receiving PFA had more (P < 0.05) docosahexaenoic acid (DHA: C22:6n-3) in their fetuses (5.23 vs. 4.04 +/- 0.078 mg/g) compared with gilts fed the control diet. Both the flax and PFA diets increased (P < 0.05) DHA (0.60, 0.82, and 0.85 +/- 0.078 mg/g for the control, flax, and PFA diet, respectively) in the chorioallantois. In the endometrium, EPA and docosapentaenoic acid (C22:5n-3) were increased by the flax diet (P < 0.001; P < 0.05), whereas gilts receiving PFA had increased DHA (P < 0.001). The flax diet selectively increased EPA, and the PFA diet selectively increased DHA in the fetus and endometrium. In Exp. 2, gilts were fed diets containing PFA (1.5%) or a control diet beginning at approximately 170 of age (n = 13/treatment). A blood sample was collected after 30 d of treatment, and gilts were artificially inseminated when they were approximately 205 d old. Conceptus and endometrial samples were collected on d 11 to 19 of pregnancy. Plasma samples indicated that PFA increased (P < 0.005) circulating concentrations of EPA and DHA. Endometrial EPA was increased (P < 0.001) for gilts fed the PFA diet. In extraembryonic tissues, PFA more than doubled (P < 0.001) the EPA (0.13 vs. 0.32 +/- 0.013 mg/g) and DHA (0.39 vs. 0.85 +/- 0.05 mg/g). In embryonic tissue on d 19, DHA was increased (P < 0.05) by PFA (0.20 vs. 0.30 +/- 0.023 mg/g). Supplementing n-3 PUFA, beginning 30 d before breeding, affected endometrial, conceptus, and fetal fatty acid composition in early pregnancy. Dynamic day effects in fatty acid composition indicate this may be a critical period for maternal fatty acid resources to affect conceptus development and survival.

Effect of soluble and insoluble dietary fiber on embryo survival and sow performance.

Two experiments were conducted to evaluate the effects of soluble (SF) and insoluble (ISF) dietary fiber during gestation on embryo survival and sow performance. In Exp. 1, 43 gilts were assigned randomly to 1 of 4 experimental diets: a corn-soybean meal control (C; 1.16% SF, 9.98% ISF); a 30% oat bran high in SF (HS; 3.02% SF, 10.06% ISF); a 12% wheat straw diet high in ISF (HIS; 1.08% SF, 18.09% ISF); and a 21% soybean hull diet (HS + HIS; 2.46% SF, 24.55% ISF). Gilts were fed the experimental diets based on their initial BW to meet their daily nutrient requirements. At estrus, gilts were inseminated artificially 3 times using pooled semen. Reproductive tracts were harvested 32 d postmating (range = 28 to 35 d). Statistical analysis of data included the effects of diet with days of gestation as a covariate. There were no differences in ovulation rate among gilts fed the experimental diets (avg. = 14.1). Number of live embryos was less for HIS and HS + HIS gilts compared with C and HS (9.9 and 9.1 vs. 11.9 and 10.6, respectively; P < 0.05). Total embryo survival rate (P < 0.05) was less for gilts fed HS + HIS compared with those fed the C and HS diets. These results suggest that high dietary ISF might decrease the total embryo survival rate without affecting ovulation rate. In Exp. 2, 716 sows were used in 3 concurrent trials. In trial 1, diets included a corn-soybean meal control (C; 0.43% SF, 10.50% ISF; n = 122) or a 31% oat bran diet (HS; 1.93% SF, 8.87% ISF; n = 124). In trial 2, diets included a C (n = 97) or a 13% wheat straw diet (HIS; 1.10% SF, 17.67% ISF; n = 119), and in trial 3 sows were fed a C (n = 123) or a 21% soybean hull diet (HS + HIS; 1.50% SF, 17.77% ISF; n = 131). All diets were offered to sows beginning 2 d postmating. All sows had ad libitum access to a standard lactation diet. Statistical analysis included the effects of diet, parity group, genetic line, and season as well as their interactions. The inclusion of SF and ISF in gestation diets did not affect litter size. Sows fed the HS + HIS diet had a greater ADFI and lost less BW during lactation (P < 0.01) than sows fed C. Under the conditions of this study, feeding gestating sows increased levels of SF and ISF from d 2 after breeding to d 109 of gestation did not increase litter size.

Circulating fatty acid profiles in response to three levels of dietary omega-3 fatty acid supplementation in horses.

Fatty acids of the n-3 type confer health benefits to humans and other species. Their importance to equine physiology could include improved exercise tolerance, decreased inflammation, and improved reproductive function. The circulating fatty acid profile and the acquisition and washout of fatty acids in response to n-3 supplementation were determined for horses in the current study. A fatty acid supplement high in eicosapentaenoic (EPA) and docosahexaenoic (DHA) acid was fed to deliver EPA plus DHA at 0 (control), 10, 20, or 40 g/d to 16 mares (n = 4/group) for 28 d. Plasma was collected at -11, 3, 7, 10, 16, 23, 30, 37, 44, 70, and 87 d relative to the beginning of supplementation. Plasma was analyzed for the presence of 35 fatty acids by gas chromatography. Plasma EPA and DHA increased (P < 0.05) in a dose-responsive manner by 3 d of feeding and reached peak concentrations by 7 d. Peak EPA and DHA concentrations of the 40 g/d supplement group were approximately 13x and 10x those of controls, respectively. Plasma EPA and DHA demonstrated a steep decline (P < 0.05) from peak values by 9 d after cessation of supplementation and were near presupplementation values by 42 d. Omega-3 supplementation also increased (P < 0.05) concentrations of fatty acids C14:0, C17:1n-7, C18:1trans-11, C18:3n-6, C18:4n-3, C20:3n-6, C20:4n-6, and C22:5n-3 and decreased (P < 0.05) concentrations of C18:1cis-9 fatty acid. Seasonal effects, apparently unrelated to supplementation and likely due to the availability of fresh forage, were also noted. Unlike ruminants, there were no detectable concentrations of CLA in equine plasma. These results indicate that the circulating fatty acid milieu in horses can be influenced through targeted supplementation. Possible implications of increased n-3 plasma and tissue concentrations on specific physiological function in the equine remain to be elucidated.

Induction of fertile estrus in prepuberal gilts by treatment with a combination of pregnant mare's serum gonadotropin and human chorionic gonadotropin.

Ten trials involving 678 presumed prepuberal gilts (5.5 to 7.5 mo old) were conducted in North Carolina, Illinois and Missouri to evaluate the reproductive performance of gilts given a combination of 400 IU of pregnant mare's serum gonadotropin and 200 IU of human chorionic gonadotropin (P. G. 600). Gilts that were presumed to be prepuberal received P. G. 600 or no treatment (control) on the day of movement from finishing facilities to pens for breeding. Detection of estrus, with the aid of mature boars, was conducted daily for 28 d; gilts in estrus were mated naturally. Treatment with P. G. 600 increased the percentage in estrus within 7 (57.5 vs 40.9%) or 28 d (72.9 vs 59.5%); average interval to estrus was reduced (P less than .05) from 10.4 to 7.5 d. Farrowing rate (78.5 +/- 3.1%), number of pigs born alive (8.6 +/- .2) or dead (.26 +/- .06) and number of pigs weaned (8.0 +/- .2) were unaffected by treatment. Gilts that were heavier than the median for each farm were in heat sooner and more were detected in heat, but no other reproductive traits differed between heavy and light gilts. Overall, the results reveal that P. G. 600 was useful for induction of fertile estrus in prepuberal gilts.

Control of the oestrous cycle in mares with altrenogest.

The clinical effectiveness of the synthetic progestagen, altrenogest, was evaluated in field trials with 449 mares during the 1980 breeding season. An oral dose of 27 mg altrenogest was administered daily for 15 days. In the first trial treated mares were compared with controls, and in the second trial the effectiveness of treatment for prolonged or erratic spring oestrus was evaluated. Oestrus was suppressed in 94% of the treated mares in the first trial. The post-treatment response was related to the stage during the transition from winter anoestrus to the spring breeding season and degree of ovarian activity when mares were treated. In mares treated during the early transition period (before 15 March), the mean diameter of the largest follicle was about 1.4 cm. There were no differences (P greater than 0.05) in the duration of oestrus or interval to conception between treated (13.0, 41 days) and control (16.6, 39 days) mares. In mares treated after 15 March (late transition period), the mean diameter of the largest follicle was about 2.1 cm and the duration of oestrus and interval to conception was less (P less than 0.05) in treated (7.7, 28 days) than in control (12.1, 40 days) mares. The duration of oestrus and interval to conception was also less (P less than 0.05) for mares treated during the late transition period than in those treated early. More (P less than 0.05) mares treated during the late transition period (75%) exhibited regular post-treatment oestrous cycles than did controls (57%) or mares treated during the early transition period (55%). The mean interval to oestrus after treatment was 4.4 days. There were no differences in pregnancy rates among any of the groups. In the second trial, 78% of the mares had exhibited oestrus for 9-30 days before treatment. All mares returned to oestrus within 10 days after altrenogest treatment: 56% conceived within 18 days and 80% within 45 days.

Influence of follicular size on the response of mares to allyl trenbolone given before the onset of the ovulatory season.

The progestin, allyl trenbolone, was given orally to mares for 15 days before the beginning of the ovulatory season. At the onset of treatment, the largest follicle was <20 mm, 20-25 mm, or >30 mm. The progestin did not hasten the onset of the ovulatory season, regardless of the diameter of largest follicle at the onset of treatment. The progestin did not alter the numbers or diameters of follicles when treatment was initiated when the largest follicle was <20 mm. However, initiation of treatment when the largest follicle was 20-25 mm or >30 mm resulted in suppressed follicular growth. Concentrations of FSH were elevated in all three progestin-treated groups, although the increase was not significant in the group with a large follicle at the onset of treatment. The compound reduced the protracted period of estrus and follicular development which commonly precedes the first ovulation of the breeding season. The number of estrous determinations and inseminations was reduced without an apparent reduction in conception rate.

Fertility, ovulation and maturation of eggs in mares injected with HCG.

Pony mares were observed from January to August for incidence of oestrus, duration of oestrus, length of the oestrous cycle and for ovulation and fertility after injection of HCG. From January to 15 May most mares showed oestrus but the duration of oestrus was quite variable and few mares ovulated in response to HCG. From 15 May to 17 August oestrous cycles were more regular and ovulation was induced within 40-50 h by an intramuscular injection of 1500-5000 i.u. HCG. Pregnancy was established by one mating at a fixed time after HCG in 20 of 69 mares. Degenerate eggs were recovered from the oviducts of anoestrous recently ovulated, mated, unmated and pregnant mares. The first polar body was formed before ovulation in 2 eggs and had not formed in 2 recently ovulated eggs flushed from the oviduct. The second polar body formed after sperm penetration 10-12 h after ovulation. After formation of pronuclei, the first cleavage division occurred at 20 h and the second at 32 h after ovulation. Oestrus was inhibited by progesterone administered by vaginal devices but occurred within 1-3 days in 12 of the 20 mares after withdrawal of the devices.

In vitro and in vivo considerations of a novel matrix-controlled bovine progesterone-releasing intravaginal device.

An in vitro system measuring progesterone release from silicone matrixes into serum is described. Drug release followed a matrix-controlled diffusion model in which the cumulative quantity released was linear with the square root of time. A bovine intravaginal device, consisting of a steel coil coated on both sides with a progesterone silicone matrix, was used as an in vivo drug delivery system. In vivo drug release also was matrix controlled, with rates comparable to those obtained in vitro. However, lag times of 1.7 and 4.2 days before reaching the steady-state rate were obtained for the outer and inner surfaces, respectively. The combination of effects resulted in a pseudo-zero-order drug-releasing device in which cumulative drug released was linear with time for at least 16 days.